Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_assertion description "[Here, using a novel small-molecule BET bromodomain inhibitor, JQ1, and the EZH2 inhibitor, DZNep, we demonstrated that combined treatment of JQ1 and DZNep cooperatively disrupted MYC activation, resulting in a greater restoration of miR-26a expression and synergistically suppressed lymphoma growth and clonogenicity in aggressive lymphoma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_assertion evidence source_evidence_literature NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_assertion SIO_000772 23538750 NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_assertion wasDerivedFrom befree-20150227 NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_assertion wasGeneratedBy ECO_0000203 NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.
- befree-20150227 importedOn "2015-02-27" NP388764.RAkOk09J6KynvT-S4nwpKkTa8oWiSSwkI32O__k4eEm2c130_provenance.